Literature DB >> 17305533

Diltiazem analogues: the last ten years on structure activity relationships.

Roberta Budriesi1, Barbara Cosimelli, Pierfranco Ioan, Emanuele Carosati, Maria P Ugenti, Rraffaella Spisani.   

Abstract

Cardiovascular diseases as hypertension, angina and/or supraventricular arrhythmias are among the most important death causes in the world. For the treatment of heart pathologies, calcium channel entry blockers are very important drugs, owing to their therapeutic versatility. Although few calcium antagonists described until today are structurally related to diltiazem and to the benzothiazepine class, the still high pharmaceutical interest on diltiazem analogues justifies this review. Diltiazem and its first analogues developed in the early '70s became popular in the '80s, and were pharmacologically characterized for a long time. It is in the '90s that several research groups carried out structural variations identifying novel scaffolds for diltiazem-related compounds, with significant calcium antagonist behaviour. Recently, a series of thiazino-oxadiazolone derivatives were identified as potent and selective antagonists for calcium influx into cardiac cells, and they were subsequently used to search for novel chemotypes by means of virtual screening techniques. The resulting hits could open interesting perspectives for the development of drugs to treat cardiovascular diseases. In the present review, an updated collection of diltiazem analogues is reported over the last ten years. The chemical structure and the structure activity relationships will be given, with additional mention to the potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305533     DOI: 10.2174/092986707779941122

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels.

Authors:  Heng Yu Zhang; Ping Liao; Jue Jin Wang; De Jie Yu; Tuck Wah Soong
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  8-(2-Chloro-phen-yl)-1-(4-chloro-phen-yl)-4-[(E)-(2-chloro-phen-yl)methyl-idene]-6-methyl-4,5,6,7,7a,8-hexa-hydro-1,2,4-oxadiazolo[5,4-d]pyrido[3,4-c][1,5]benzothia-zepine.

Authors:  V Rajni Swamy; R Sudha Periathai; K Rajagopal; R V Krishnakumar; N Srinivasan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.